82 FR 10023 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 26 (February 9, 2017)

Page Range		10023-10023
FR Document		2017-02620

Federal Register, Volume 82 Issue 26 (Thursday, February 9, 2017)

[Federal Register Volume 82, Number 26 (Thursday, February 9, 2017)]
[Notices]
[Page 10023]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-02620]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
    Date: March 6, 2017.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Kelly Y. Poe, Ph.D., Scientific Review Office, 
Scientific Review Program, Division of Extramural Activities, Room 
3F40B, National Institutes of Health, NIAID, 5601 Fishers Lane, MSC 
9823, Bethesda, MD 20892-9823, (240) 669-5036, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: February 3, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-02620 Filed 2-8-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 26 / Thursday, February 9, 2017 / Notices 10023

• Low toxicity. DEPARTMENT OF HEALTH AND 93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
• Specific for Aspergillus. HUMAN SERVICES
HHS)
Development Stage National Institutes of Health Dated: February 3, 2017.
• In vivo data available (animal). National Cancer Institute; Notice of Melanie J. Pantoja,
Inventors: Peter R. Williamson Closed Meetings Program Analyst, Office of Federal Advisory
Committee Policy.
(NIAID), Dale O. Kiesewetter (NIBIB), Pursuant to section 10(d) of the
[FR Doc. 2017–02615 Filed 2–8–17; 8:45 am]
John C. Panepinto (University of Federal Advisory Committee Act, as
Buffalo), and Jin Qiu (NIAID). BILLING CODE 4140–01–P
amended (5 U.S.C. App.), notice is
hereby given of meetings of the Board of
Publications
Scientific Counselors for Basic Sciences,
National Cancer Institute and the Board DEPARTMENT OF HEALTH AND
1. Palmer GE, et al., The diverse roles HUMAN SERVICES
of autophagy in medically important of Scientific Counselors for Clinical
fungi, Autophagy. 2008 Nov; 4(8):982–8. Sciences and Epidemiology, National
National Institutes of Health
[PMID 18927489] Cancer Institute.
The meetings will be closed to the National Institute of Allergy and
2. Panepinto JC, et al., Deletion of the public as indicated below in accordance
Aspergillus fumigatus gene encoding Infectious Diseases; Notice of Closed
with the provisions set forth in section
the Ras-related protein RhbA reduces Meeting
552b(c)(6), Title 5 U.S.C., as amended
virulence in a model of invasive for the review, discussion, and
pulmonary aspergillosis, Infect Immun. Pursuant to section 10(d) of the
evaluation of individual intramural
2003 May; 71(5):2819–26. [PMID Federal Advisory Committee Act, as
programs and projects conducted by the
12704156] amended (5 U.S.C. App.), notice is
National Cancer Institute, including
consideration of personnel hereby given of the following meeting.
3. Desoubeaux D, et al., Diagnosis of
invasive pulmonary aspergillosis: qualifications and performance, and the The meeting will be closed to the
Updates and recommendations, Med competence of individual investigators, public in accordance with the
Mal Infect. 2014 Mar; 44(3):89–101. the disclosure of which would provisions set forth in sections
[PMID 24548415] constitute a clearly unwarranted 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
invasion of personal privacy. as amended. The contract proposals and
Intellectual Property: HHS Reference the discussions could disclose
Name of Committee: Board of Scientific
Nos. E–449–2013/0,1—U.S. Provisional Counselors for Clinical Sciences and confidential trade secrets or commercial
Application No. 61/894,754, filed Epidemiology, National Cancer Institute. property such as patentable material,
October 23, 2013; PCT Application No. Date: March 6, 2017. and personal information concerning
PCT/US2014/061917, filed October 23, Time: 8:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate personal
individuals associated with the contract
2014 (published as WO 2015/061540 on proposals, the disclosure of which
qualifications and performance, and
April 30, 2015); European Application would constitute a clearly unwarranted
competence of individual investigators.
No. 14800182.9, filed October 23, 2014 Place: National Institutes of Health, 31 invasion of personal privacy.
(pending); Australian Application No. Center Drive, Building 31, C–Wing, 6th Floor,
2014340035, filed October 23, 2014 Conference Room 6, Bethesda, MD 20892. Name of Committee: National Institute of
Contact Person: Brian E. Wojcik, Ph.D., Allergy and Infectious Diseases Special
(pending); Canadian Application No.
Senior Review Administrator, Institute Emphasis Panel; NIAID Peer Review Meeting.
2927952, filed October 23, 2014; and
Review Office, Office of the Director, Date: March 6, 2017.
U.S. Application No. 15/030,554, filed National Cancer Institute, National Institutes Time: 1:00 p.m. to 3:00 p.m.
April 19, 2016 (pending). of Health, 9609 Medical Center Drive, Room Agenda: To review and evaluate contract
Licensing Contact: Dr. David Yang, 3W414, Bethesda, MD 20892, 240–276–5664, proposals.
240–627–3413; polung.yang@nih.gov. wojcikb@mail.nih.gov. Place: National Institutes of Health, 5601
Name of Committee: Board of Scientific Fishers Lane, Rockville, MD 20892
Collaborative Research Opportunity: Counselors for Basic Sciences, National (Telephone Conference Call).
The National Institute of Allergy and Cancer Institute. Contact Person: Kelly Y. Poe, Ph.D.,
Infectious Diseases is seeking statements Date: March 7, 2017.
Scientific Review Office, Scientific Review
of capability or interest from parties Time: 9:00 a.m. to 12:15 p.m.
Agenda: To review and evaluate personal Program, Division of Extramural Activities,
interested in collaborative research to Room 3F40B, National Institutes of Health,
further develop, evaluate or qualifications and performance, and
competence of individual investigators. NIAID, 5601 Fishers Lane, MSC 9823,
commercialize for development of this Place: National Institutes of Health, 31 Bethesda, MD 20892–9823, (240) 669–5036,
invention. For collaboration Center Drive, Building 31, C–Wing, 6th Floor, poeky@mail.nih.gov.
opportunities, please contact Dr. David Conference Room 6, Bethesda, MD 20892. (Catalogue of Federal Domestic Assistance
Yang, 240–627–3413; polung.yang@ Contact Person: Mehrdad Tondravi, Ph.D., Program Nos. 93.855, Allergy, Immunology,
nih.gov. Chief, Institute Review Office, Office of the
and Transplantation Research; 93.856,
Director, National Cancer Institute, National
Dated: February 6, 2017. Institutes of Health, 9609 Medical Center Microbiology and Infectious Diseases
Suzanne Frisbie, Drive, Room 3W–302, Bethesda, MD 20892, Research, National Institutes of Health, HHS)
sradovich on DSK3GMQ082PROD with NOTICES

240–276–5664, tondravim@mail.nih.gov. Dated: February 3, 2017.
Deputy Director, Technology Transfer and
Intellectual Property Office, National Institute (Catalogue of Federal Domestic Assistance Natasha M. Copeland,
of Allergy and Infectious Diseases. Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention Program Analyst, Office of Federal Advisory
[FR Doc. 2017–02674 Filed 2–8–17; 8:45 am] Committee Policy.
Research; 93.394, Cancer Detection and
BILLING CODE 4140–01–P Diagnosis Research; 93.395, Cancer [FR Doc. 2017–02620 Filed 2–8–17; 8:45 am]
Treatment Research; 93.396, Cancer Biology BILLING CODE 4140–01–P
Research; 93.397, Cancer Centers Support;

VerDate Sep<11>2014 18:11 Feb 08, 2017 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 9990 E:\FR\FM\09FEN1.SGM 09FEN1

Document Created: 2017-02-09 01:03:09
Document Modified: 2017-02-09 01:03:09

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		March 6, 2017.
FR Citation		82 FR 10023

82 FR 10023 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 26 (February 9, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health